Comparison	O	NOUN	B
with	O	ADP	O
alkaline	B-GENE	NOUN	B
phosphatases	I-GENE	NOUN	I
and	O	CCONJ	O
5	B-GENE	NUM	B
-	I-GENE	PUNCT	O
nucleotidase	I-GENE	NOUN	B


Serum	B-GENE	NOUN	B
gamma	I-GENE	NOUN	I
glutamyltransferase	I-GENE	NOUN	I
in	O	ADP	O
the	O	DET	O
diagnosis	O	NOUN	B
of	O	ADP	O
liver	O	NOUN	B
disease	O	NOUN	I
in	O	ADP	O
cattle	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
secretory	B-GENE	ADJ	B
HI	I-GENE	NOUN	I
antibodies	I-GENE	NOUN	I
were	O	AUX	O
not	O	PART	O
demonstrated	O	VERB	O
at	O	ADP	O
the	O	DET	O
onset	O	NOUN	B
of	O	ADP	I
illness	O	NOUN	B
in	O	ADP	O
any	O	DET	O
of	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
their	O	PRON	O
formation	O	NOUN	B
started	O	VERB	O
early	O	ADV	B
and	O	CCONJ	O
the	O	DET	O
antibodies	O	NOUN	B
reached	O	VERB	O
maximal	O	ADJ	B
levels	O	NOUN	B
about	O	ADP	O
10	O	NUM	O
days	O	NOUN	B
after	O	ADP	O
onset	O	NOUN	B
of	O	ADP	I
illness	O	NOUN	I
.	O	PUNCT	O


Takayasu	O	NOUN	B
'	O	PART	I
s	O	NOUN	I
disease	O	NOUN	B
:	O	PUNCT	O
association	O	NOUN	B
with	O	ADP	O
HLA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
B5	I-GENE	NOUN	B
.	O	PUNCT	O


Selective	O	ADJ	O
stimulation	O	NOUN	B
of	O	ADP	O
central	O	ADJ	B
alpha	B-GENE	NOUN	I
-	I-GENE	PUNCT	O
autoreceptors	I-GENE	NOUN	B
following	O	VERB	O
treatment	O	NOUN	B
with	O	ADP	O
alpha	O	NOUN	B
-	O	PUNCT	O
methyldopa	O	NOUN	B
and	O	CCONJ	O
FLA	O	PROPN	B
136	O	NUM	O
.	O	PUNCT	O


Studies	O	NOUN	B
on	O	ADP	O
immunoglobulin	B-GENE	NOUN	B
E	I-GENE	NOUN	I
:	O	PUNCT	O
the	O	DET	O
impact	O	NOUN	B
of	O	ADP	O
a	O	DET	O
sojourn	O	NOUN	B
with	O	ADP	O
Professor	O	PROPN	B
Dan	O	PROPN	I
H	O	PROPN	I
.	O	PUNCT	O


Ten	O	NUM	O
out	O	ADJ	B
-	O	PUNCT	O
patients	O	NOUN	B
with	O	ADP	O
pustulosis	O	NOUN	B
palmaris	O	NOUN	I
et	O	X	O
plantaris	O	NOUN	B
were	O	AUX	O
examined	O	VERB	O
with	O	ADP	O
direct	O	ADJ	B
immunofluorescence	O	NOUN	I
(	O	PUNCT	O
IF	O	NOUN	B
)	O	PUNCT	O
technique	O	NOUN	B
for	O	ADP	O
deposition	O	NOUN	B
of	O	ADP	O
fibrinogen	B-GENE	NOUN	B
,	O	PUNCT	O
fibrin	B-GENE	NOUN	B
or	O	CCONJ	O
its	O	PRON	O
degradation	O	NOUN	B
products	O	NOUN	I
(	O	PUNCT	O
FR	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
antigen	I-GENE	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
affected	O	VERB	B
and	O	CCONJ	O
unaffected	O	ADJ	B
skin	O	NOUN	B
,	O	PUNCT	O
together	O	ADV	O
with	O	ADP	O
heparin	O	NOUN	B
-	O	PUNCT	O
precipitable	O	ADJ	B
fraction	O	NOUN	O
(	O	PUNCT	O
HPF	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
cryoglobulin	B-GENE	NOUN	B
and	O	CCONJ	O
total	O	ADJ	O
plasma	O	NOUN	O
fibrinogen	B-GENE	NOUN	O
in	O	ADP	O
the	O	DET	O
blood	O	NOUN	B
.	O	PUNCT	O


False	O	ADJ	B
positive	O	ADJ	I
amniotic	B-GENE	ADJ	B
fluid	I-GENE	ADJ	I
alpha	I-GENE	NOUN	I
fetoprotein	I-GENE	NOUN	O
levels	O	NOUN	O
resulting	O	VERB	O
from	O	ADP	O
contamination	O	NOUN	B
with	O	ADP	O
fetal	O	ADJ	B
blood	O	NOUN	I
:	O	PUNCT	O
results	O	NOUN	B
of	O	ADP	O
an	O	DET	O
experiment	O	NOUN	B
.	O	PUNCT	O


Albumin	B-GENE	NOUN	B
and	O	CCONJ	O
cyclic	O	ADJ	B
AMP	O	NOUN	B
levels	O	NOUN	B
in	O	ADP	O
peritoneal	O	ADJ	B
fluids	O	NOUN	I
in	O	ADP	O
the	O	DET	O
child	O	NOUN	B


The	O	DET	O
concentration	O	NOUN	B
of	O	ADP	O
alpha	B-GENE	NOUN	B
2	I-GENE	NUM	I
-	I-GENE	PUNCT	O
macroglobulin	I-GENE	NOUN	B
,	O	PUNCT	O
alpha	B-GENE	NOUN	B
1	I-GENE	NUM	I
-	I-GENE	PUNCT	O
antitrypsin	I-GENE	NOUN	B
,	O	PUNCT	O
plasminogen	B-GENE	NOUN	B
,	O	PUNCT	O
C3	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
complement	I-GENE	NOUN	B
,	O	PUNCT	O
fibrinogen	B-GENE	NOUN	B
degradation	I-GENE	NOUN	I
products	I-GENE	NOUN	I
(	O	PUNCT	O
FDP	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
fibrinolytic	O	ADJ	B
activity	O	NOUN	I
,	O	PUNCT	O
were	O	AUX	O
studied	O	VERB	O
in	O	ADP	O
the	O	DET	O
aqueous	O	ADJ	B
humour	O	NOUN	B
and	O	CCONJ	O
serum	O	NOUN	B
from	O	ADP	O
nine	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
Fuchs	O	NOUN	B
'	O	PART	O
endothelial	O	ADJ	B
dystrophy	O	NOUN	I
,	O	PUNCT	O
17	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
uncomplicated	O	ADJ	B
senile	O	ADJ	B
cataract	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
secondary	O	ADJ	B
aqueous	O	ADJ	B
from	O	ADP	O
six	O	NUM	O
cataract	O	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
CBZ	O	NOUN	B
and	O	CCONJ	O
DPH	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
explained	O	VERB	O
by	O	ADP	O
interference	O	NOUN	B
with	O	ADP	O
thyroid	O	NOUN	B
hormone	O	NOUN	I
binding	O	NOUN	I
to	O	PART	O
TBG	B-GENE	NOUN	B
combined	O	VERB	O
with	O	ADP	O
enzyme	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
increased	O	VERB	B
metabolic	O	ADJ	B
clearance	O	NOUN	O
rate	O	NOUN	B
of	O	ADP	O
thyroid	O	NOUN	B
hormones	O	NOUN	I
without	O	ADP	O
homeostatic	O	ADJ	B
maintenance	O	NOUN	B
of	O	ADP	O
premedication	O	NOUN	B
levels	O	NOUN	B
of	O	ADP	O
FT4	O	NOUN	B
and	O	CCONJ	O
FT3	O	NOUN	B
.	O	PUNCT	O


Eight	O	NUM	B
hours	O	NOUN	I
after	O	ADP	O
the	O	DET	O
administration	O	NOUN	B
of	O	ADP	O
colchicine	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
serum	B-GENE	NOUN	B
ceruloplasmin	I-GENE	NOUN	B
level	O	NOUN	B
began	O	VERB	O
to	O	PART	O
rise	O	VERB	O
again	O	ADV	O
in	O	ADP	O
female	O	ADJ	B
rats	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
male	O	NOUN	B
rats	O	NOUN	B
.	O	PUNCT	O


Ectopic	O	ADJ	B
ACTH	B-GENE	NOUN	I
syndrome	O	NOUN	I
and	O	CCONJ	O
medullary	O	ADJ	B
thyroid	O	NOUN	I
carcinoma	O	NOUN	I
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
no	O	DET	O
correlation	O	NOUN	B
between	O	ADP	O
serum	B-GENE	NOUN	B
LH	I-GENE	NOUN	B
and	O	CCONJ	O
chronological	O	ADJ	B
or	O	CCONJ	O
bone	O	NOUN	B
age	O	NOUN	I
in	O	ADP	O
this	O	DET	O
age	O	NOUN	B
group	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
suggests	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
correlation	O	NOUN	B
found	O	VERB	O
is	O	AUX	O
not	O	PART	O
due	O	ADJ	O
to	O	ADP	O
age	O	NOUN	B
-	O	PUNCT	O
related	O	ADJ	B
parallel	O	ADJ	O
phenomena	O	NOUN	B
.	O	PUNCT	O


Effect	O	NOUN	B
of	O	ADP	O
succimer	O	NOUN	B
on	O	ADP	O
the	O	DET	O
intensity	O	NOUN	B
of	O	ADP	O
tricarboxylic	B-GENE	ADJ	B
acid	I-GENE	NOUN	I
dehydrogenase	I-GENE	NOUN	I
reactions	O	NOUN	I
in	O	ADP	O
the	O	DET	O
brain	O	NOUN	B
of	O	ADP	O
rats	O	NOUN	B
poisoned	O	VERB	B
with	O	ADP	O
mercuric	O	ADJ	B
chloride	O	NOUN	I


Total	O	ADJ	B
VO2	O	NOUN	B
was	O	AUX	O
decreased	O	VERB	B
in	O	ADP	O
both	O	DET	O
groups	O	NOUN	B
during	O	ADP	O
severe	O	ADJ	B
hypoxia	O	NOUN	B
but	O	CCONJ	O
limb	O	NOUN	B
VO2	O	NOUN	B
was	O	AUX	O
maintained	O	VERB	B
in	O	ADP	O
the	O	DET	O
beta	O	NOUN	B
-	O	PUNCT	O
block	O	NOUN	B
group	O	NOUN	B
.	O	PUNCT	O
beta	O	NOUN	B
-	O	PUNCT	O
Block	O	PROPN	B
prevented	O	VERB	B
the	O	DET	O
fall	O	NOUN	B
in	O	ADP	O
total	O	NOUN	O
and	O	CCONJ	O
limb	O	ADJ	B
peripheral	O	ADJ	I
resistance	O	NOUN	I
seen	O	VERB	O
in	O	ADP	O
severe	O	ADJ	B
hypoxia	O	NOUN	B
but	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
alter	O	VERB	O
the	O	DET	O
consistently	O	ADV	O
more	O	ADV	O
efficient	O	ADJ	B
utilization	O	NOUN	B
of	O	ADP	O
total	O	ADJ	O
O2	O	NOUN	B
delivery	O	NOUN	B
shown	O	VERB	O
by	O	ADP	O
the	O	DET	O
limb	O	NOUN	B
in	O	ADP	O
comparison	O	NOUN	B
to	O	ADP	O
the	O	DET	O
whole	O	ADJ	B
body	O	NOUN	I
by	O	ADP	O
higher	O	ADJ	B
O2	O	NOUN	B
extraction	O	NOUN	I
ratios	O	NOUN	B
and	O	CCONJ	O
lower	O	ADJ	O
venous	O	ADJ	B
O2	O	NOUN	I
pressure	O	NOUN	I
.	O	PUNCT	O
beta	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Vasodilator	I-GENE	NOUN	B
receptors	I-GENE	NOUN	I
evidently	O	ADV	O
played	O	VERB	O
an	O	DET	O
active	O	ADJ	B
part	O	NOUN	O
in	O	ADP	O
the	O	DET	O
vasodilatation	O	NOUN	B
seen	O	VERB	O
during	O	ADP	O
severe	O	ADJ	B
hypoxia	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
both	O	CCONJ	O
these	O	DET	O
respects	O	NOUN	O
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
DBP	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
resembles	O	VERB	O
the	O	DET	O
late	O	ADJ	B
messengers	O	NOUN	I
of	O	ADP	O
SV40	O	NOUN	B
and	O	CCONJ	O
polyoma	O	NOUN	B
viruses	O	NOUN	I
.	O	PUNCT	O


Effect	O	NOUN	B
of	O	ADP	O
corticosteroid	O	NOUN	B
-	O	PUNCT	O
containing	O	VERB	B
antirheumatic	O	ADJ	B
combination	O	NOUN	I
drugs	O	NOUN	I
on	O	ADP	O
endogenous	O	ADJ	B
ACTH	B-GENE	NOUN	B
and	O	CCONJ	O
cortisol	O	NOUN	B
production	O	NOUN	I
.	O	PUNCT	O


Dopamine	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
blockade	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
neuroleptics	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
crystallographic	O	ADJ	B
study	O	NOUN	I
.	O	PUNCT	O


Similarly	O	ADV	O
,	O	PUNCT	O
maternal	B-GENE	ADJ	B
serum	I-GENE	NOUN	B
somatomedin	I-GENE	NOUN	B
A	I-GENE	NOUN	I
was	O	AUX	O
significantly	O	ADV	O
reduced	O	VERB	B
in	O	ADP	O
rats	O	NOUN	B
nursing	O	NOUN	B
large	O	ADJ	O
litters	O	NOUN	B
.	O	PUNCT	O


High	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
serum	O	NOUN	B
calcitonin	B-GENE	NOUN	I
were	O	AUX	O
found	O	VERB	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
chronic	O	ADJ	B
renal	O	ADJ	I
failure	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
response	O	NOUN	B
of	O	ADP	O
serum	B-GENE	NOUN	O
GH	I-GENE	NOUN	B
to	O	PART	O
arginine	O	NOUN	B
infusion	O	NOUN	B
was	O	AUX	O
normal	O	ADJ	B
,	O	PUNCT	O
while	O	SCONJ	O
that	O	DET	O
to	O	PART	O
insulin	B-GENE	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
hypoglycemia	O	NOUN	B
was	O	AUX	O
poor	O	ADJ	B
.	O	PUNCT	O


Hepatic	O	ADJ	B
oxygen	O	NOUN	I
supply	O	NOUN	I
and	O	CCONJ	O
selected	O	VERB	O
blood	O	NOUN	B
parameters	O	NOUN	I
were	O	AUX	O
recorded	O	VERB	O
in	O	ADP	O
fasted	O	VERB	B
male	O	NOUN	B
rates	O	NOUN	B
given	O	VERB	O
20	O	NUM	O
-	O	PUNCT	O
-	O	PUNCT	O
30	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
Escherichia	B-GENE	X	B
coli	I-GENE	X	I
endotoxin	I-GENE	NOUN	B
intraperitoneally	O	ADV	B
.	O	PUNCT	O


Basal	O	ADJ	B
FSH	B-GENE	NOUN	B
and	O	CCONJ	O
LH	B-GENE	NOUN	B
levels	O	NOUN	B
were	O	AUX	O
significantly	O	ADV	O
lower	O	ADJ	O
in	O	ADP	O
addicts	O	NOUN	B
;	O	PUNCT	O
after	O	ADP	O
GnRH	B-GENE	NOUN	B
stimulation	O	NOUN	B
the	O	DET	O
addicts	O	NOUN	B
'	O	PART	O
FSH	B-GENE	NOUN	B
and	O	CCONJ	O
LH	B-GENE	NOUN	B
values	O	NOUN	B
increased	O	VERB	B
but	O	CCONJ	O
not	O	PART	O
significantly	O	ADV	O
compared	O	VERB	O
to	O	PART	O
controls	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
article	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
clinical	O	ADJ	B
actions	O	NOUN	I
of	O	ADP	O
the	O	DET	O
principal	O	ADJ	B
dopamine	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
stimulating	O	NOUN	O
agents	O	NOUN	O
(	O	PUNCT	O
apomorphine	O	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
derivatives	O	NOUN	B
;	O	PUNCT	O
piribedil	O	NOUN	B
,	O	PUNCT	O
rye	O	NOUN	B
-	O	PUNCT	O
ergot	O	NOUN	B
derivatives	O	NOUN	I
)	O	PUNCT	O
are	O	AUX	O
discussed	O	VERB	O
on	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
their	O	PRON	O
biochemical	O	ADJ	B
and	O	CCONJ	O
pharmacological	O	ADJ	B
properties	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
patients	O	NOUN	B
who	O	PRON	O
had	O	AUX	O
received	O	VERB	O
no	O	DET	O
previous	O	ADJ	O
drug	O	NOUN	B
treatment	O	NOUN	I
,	O	PUNCT	O
log	O	NOUN	B
baseline	O	NOUN	B
plasma	B-GENE	NOUN	B
renin	I-GENE	NOUN	B
activity	O	NOUN	B
and	O	CCONJ	O
change	O	NOUN	B
in	O	ADP	O
mean	O	ADJ	B
blood	O	NOUN	I
pressure	O	NOUN	I
after	O	ADP	O
SQ	O	NOUN	B
20881	O	NUM	I
correlated	O	VERB	B
significantly	O	ADV	O
(	O	PUNCT	O
r	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
651	O	NUM	O
,	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Plasma	O	NOUN	B
ion	O	NOUN	O
changes	O	NOUN	B
in	O	ADP	O
venous	O	ADJ	B
blood	O	NOUN	I
incubated	O	VERB	B
with	O	ADP	O
beta	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
blockers	O	NOUN	I
and	O	CCONJ	O
subjected	O	VERB	O
to	O	ADP	O
tonometry	O	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


Such	O	ADJ	O
marked	O	ADJ	O
differences	O	NOUN	B
are	O	AUX	O
found	O	VERB	O
occasionally	O	ADV	O
in	O	ADP	O
the	O	DET	O
literature	O	NOUN	B
:	O	PUNCT	O
heterophile	O	NOUN	B
antibodies	O	NOUN	I
against	O	ADP	O
bovine	B-GENE	ADJ	B
gammaglobulin	I-GENE	NOUN	I
are	O	AUX	O
regarded	O	VERB	O
as	O	ADP	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
interference	O	NOUN	B
in	O	ADP	O
the	O	DET	O
Sephadex	O	NOUN	B
system	O	NOUN	I
of	O	ADP	O
RIST	O	NOUN	B
.	O	PUNCT	O


Serial	O	ADJ	O
measurements	O	NOUN	B
of	O	ADP	O
total	O	ADJ	O
serum	O	NOUN	O
IgE	B-GENE	NOUN	O
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
useful	O	ADJ	O
index	O	NOUN	O
of	O	ADP	O
disease	O	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
ABPA	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
rise	O	NOUN	O
of	O	ADP	O
hemoglobin	B-GENE	NOUN	B
concentration	O	NOUN	I
accompanied	O	VERB	O
by	O	ADP	O
an	O	DET	O
increase	O	NOUN	B
of	O	ADP	O
the	O	DET	O
total	O	ADJ	O
iron	O	NOUN	B
in	O	ADP	O
the	O	DET	O
blood	O	NOUN	B
serum	O	NOUN	I
of	O	ADP	O
white	O	ADJ	B
mice	O	NOUN	I
was	O	AUX	O
found	O	VERB	O
under	O	ADP	O
oxygen	O	NOUN	B
pressure	O	NOUN	I
of	O	ADP	O
4	O	NUM	O
atm	O	NOUN	O
for	O	ADP	O
an	O	DET	O
hour	O	NOUN	B
(	O	PUNCT	O
preconvulsive	O	ADJ	B
state	O	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
6	O	NUM	O
atm	O	NOUN	O
(	O	PUNCT	O
convulsive	O	ADJ	B
state	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Carbohydrate	O	NOUN	B
metabolism	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
semen	O	NOUN	B
profile	O	NOUN	I
:	O	PUNCT	O
glucose	O	NOUN	B
,	O	PUNCT	O
insulin	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
sperm	O	NOUN	B
studies	O	NOUN	B
.	O	PUNCT	O


Urinary	O	ADJ	B
excretion	O	NOUN	B
of	O	ADP	O
oestrone	O	NOUN	B
,	O	PUNCT	O
oestradiol	O	NOUN	B
-	O	PUNCT	O
17	O	NUM	O
beta	O	NOUN	B
and	O	CCONJ	O
oestriol	O	NOUN	B
in	O	ADP	O
pregnancies	O	NOUN	B
complicated	O	VERB	O
by	O	ADP	O
steroid	B-GENE	NOUN	B
sulphatase	I-GENE	NOUN	I
deficiency	O	NOUN	I
.	O	PUNCT	O


Irradiation	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
blood	O	NOUN	O
platelets	O	NOUN	O
with	O	ADP	O
UV	O	NOUN	B
-	O	PUNCT	O
A	O	NOUN	B
in	O	X	B
vitro	O	X	I
impairs	O	VERB	B
their	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
aggregate	O	VERB	B
after	O	ADP	O
challenge	O	NOUN	O
with	O	ADP	O
collagen	B-GENE	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
measured	O	VERB	B
basal	O	ADJ	B
plasma	O	NOUN	I
prolactin	B-GENE	NOUN	B
concentrations	O	NOUN	I
(	O	PUNCT	O
in	O	ADP	O
samples	O	NOUN	B
obtained	O	VERB	O
during	O	ADP	O
the	O	DET	O
early	O	ADJ	O
follicular	O	ADJ	B
phase	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
25	O	NUM	O
normal	O	ADJ	B
(	O	PUNCT	O
control	O	NOUN	B
)	O	PUNCT	O
women	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
a	O	DET	O
similar	O	ADJ	O
group	O	NOUN	B
of	O	ADP	O
40	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
a	O	DET	O
long	O	ADV	B
-	O	PUNCT	O
standing	O	VERB	B
history	O	NOUN	O
of	O	ADP	O
infertility	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
girls	O	NOUN	B
prolactin	B-GENE	NOUN	B
levels	O	NOUN	I
rise	O	VERB	O
at	O	ADP	O
stage	O	NOUN	B
2	O	NUM	I
,	O	PUNCT	O
and	O	CCONJ	O
are	O	AUX	O
higher	O	ADJ	O
after	O	ADP	O
menarche	O	NOUN	B
;	O	PUNCT	O
in	O	ADP	O
boys	O	NOUN	B
there	O	PRON	O
is	O	AUX	O
no	O	DET	O
change	O	NOUN	O
in	O	ADP	O
prolactin	B-GENE	NOUN	B
levels	O	NOUN	I
.	O	PUNCT	O


Serum	O	NOUN	B
levels	O	NOUN	O
of	O	ADP	O
IgG	B-GENE	NOUN	B
and	O	CCONJ	O
IgM	B-GENE	NOUN	B
were	O	AUX	O
also	O	ADV	O
raised	O	VERB	B
,	O	PUNCT	O
but	O	CCONJ	O
contrary	O	ADJ	O
to	O	ADP	O
the	O	DET	O
findings	O	NOUN	B
of	O	ADP	O
other	O	ADJ	O
observers	O	NOUN	B
IgA	B-GENE	NOUN	B
levels	O	NOUN	B
were	O	AUX	O
normal	O	ADJ	O
.	O	PUNCT	O


A	O	DET	O
decrease	O	NOUN	B
of	O	ADP	O
the	O	DET	O
lysozyme	B-GENE	NOUN	B
activity	O	NOUN	B
coincided	O	VERB	O
with	O	ADP	O
the	O	DET	O
clinical	O	ADJ	B
improvement	O	NOUN	I
of	O	ADP	O
the	O	DET	O
bacterial	O	ADJ	B
meningitis	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
responses	O	NOUN	B
were	O	AUX	O
compared	O	VERB	B
with	O	ADP	O
others	O	NOUN	O
in	O	ADP	O
the	O	DET	O
same	O	ADJ	O
subjects	O	NOUN	B
under	O	ADP	O
the	O	DET	O
same	O	ADJ	O
conditions	O	NOUN	B
and	O	CCONJ	O
it	O	PRON	O
was	O	AUX	O
concluded	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
antihypertensive	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
labetalol	O	NOUN	B
is	O	AUX	O
explained	O	VERB	O
by	O	ADP	O
concurrent	O	ADJ	B
blockade	O	NOUN	B
of	O	ADP	O
alpha	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
and	I-GENE	CCONJ	O
beta	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
adrenoceptors	I-GENE	NOUN	B
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
liver	O	NOUN	B
biopsy	O	NOUN	I
specimens	O	NOUN	I
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
hepatitis	O	NOUN	B
showed	O	VERB	O
a	O	DET	O
large	O	ADJ	O
variation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
mean	O	ADJ	O
iron	O	NOUN	B
content	O	NOUN	I
of	O	ADP	O
the	O	DET	O
liver	O	NOUN	B
ferritin	B-GENE	NOUN	I
molecules	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
pure	O	ADJ	O
natural	O	ADJ	B
porcine	B-GENE	NOUN	O
secretin	I-GENE	NOUN	B
on	O	ADP	O
endocrine	O	ADJ	B
and	O	CCONJ	O
exocrine	O	ADJ	B
pancreatic	O	ADJ	I
secretion	O	NOUN	I
was	O	AUX	O
studied	O	VERB	O
in	O	ADP	O
the	O	DET	O
totally	O	ADV	O
isolated	O	VERB	B
perfused	O	ADJ	B
porcine	O	NOUN	O
pancreas	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
biopsies	O	NOUN	B
CK	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
MB	I-GENE	NOUN	B
fraction	O	NOUN	B
of	O	ADP	O
total	O	ADJ	O
myocardial	O	ADJ	O
CPK	B-GENE	NOUN	B
was	O	AUX	O
37	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
total	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
CPK	I-GENE	NOUN	B
activity	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
skeletal	O	ADJ	B
muscles	O	NOUN	I
still	O	ADV	O
shows	O	VERB	O
a	O	DET	O
5	O	NUM	O
%	O	NOUN	O
fraction	O	NOUN	B
of	O	ADP	O
CK	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
MB	I-GENE	PROPN	B
.	O	PUNCT	O


Treatment	O	NOUN	B
of	O	ADP	O
hypertension	O	NOUN	B
with	O	ADP	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
the	O	DET	O
adrenergic	B-GENE	ADJ	B
beta	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
blockader	O	NOUN	I
,	O	PUNCT	O
obsidan	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
vasodilator	O	NOUN	B
,	O	PUNCT	O
apressin	O	NOUN	B


Platelet	O	NOUN	B
serotonin	O	NOUN	I
(	O	PUNCT	O
5	O	NUM	O
-	O	PUNCT	O
HT	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
5	B-GENE	NUM	B
-	I-GENE	PUNCT	O
HT	I-GENE	NOUN	B
releasing	I-GENE	NOUN	O
factor	I-GENE	NOUN	O
in	O	ADP	O
plasma	O	NOUN	B
of	O	ADP	O
migrainous	O	ADJ	B
patients	O	NOUN	B
.	O	PUNCT	O


Carcinoembryonic	B-GENE	NOUN	B
antigen	I-GENE	NOUN	I
(	O	PUNCT	O
CEA	B-GENE	NOUN	B
)	O	PUNCT	O
procedures	O	NOUN	B
and	O	CCONJ	O
clinical	O	ADJ	B
evaluation	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
diagnosis	O	NOUN	B
of	O	ADP	O
MS	O	NOUN	B
was	O	AUX	O
made	O	VERB	O
based	O	VERB	O
on	O	ADP	O
subtle	O	ADJ	O
neurologic	O	ADJ	B
signs	O	NOUN	O
,	O	PUNCT	O
spinal	O	ADJ	B
fluid	O	ADJ	I
gamma	B-GENE	NOUN	I
globulin	I-GENE	NOUN	I
elevations	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
abnormalities	O	NOUN	B
in	O	ADP	O
neuropsychological	O	ADJ	B
testing	O	NOUN	I
.	O	PUNCT	O


Recurrence	O	NOUN	B
of	O	ADP	O
bladder	O	NOUN	B
tumors	O	NOUN	I
among	O	ADP	O
the	O	DET	O
original	O	ADJ	B
9	O	NUM	O
cases	O	NOUN	B
has	O	AUX	O
occurred	O	VERB	O
only	O	ADV	O
among	O	ADP	O
the	O	DET	O
5	O	NUM	O
whose	O	DET	O
properdin	B-GENE	NOUN	B
levels	O	NOUN	O
remained	O	VERB	O
below	O	ADP	O
the	O	DET	O
median	O	NOUN	B
.	O	PUNCT	O


Treatment	O	NOUN	B
with	O	ADP	O
heparin	O	NOUN	B
,	O	PUNCT	O
plasminogen	B-GENE	NOUN	B
activators	O	NOUN	I
and	O	CCONJ	O
fibrinogenolytic	O	ADJ	B
agents	O	NOUN	I
was	O	AUX	O
disappointing	O	ADJ	O
although	O	SCONJ	O
renal	O	ADJ	B
function	O	NOUN	I
has	O	AUX	O
stabilized	O	VERB	B
in	O	ADP	O
one	O	NUM	O
patient	O	NOUN	B
on	O	ADP	O
long	O	ADJ	B
term	O	NOUN	I
oral	O	ADJ	B
anticoagulant	O	ADJ	B
therapy	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
morphological	O	ADJ	B
effects	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
snake	O	NOUN	B
venoms	O	NOUN	I
,	O	PUNCT	O
N	O	NOUN	B
.	O	PUNCT	O
naja	O	NOUN	B
and	O	CCONJ	O
A	O	NOUN	B
.	O	PUNCT	O
piscivorus	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
of	O	ADP	O
the	O	DET	O
Direct	B-GENE	ADJ	O
Lytic	I-GENE	ADJ	B
Factor	I-GENE	NOUN	I
and	O	CCONJ	O
Phospholipase	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
A	I-GENE	PROPN	B
,	O	PUNCT	O
compounds	O	NOUN	B
purified	O	VERB	B
from	O	ADP	O
N	O	NOUN	B
.	O	PUNCT	O
naja	O	NOUN	B
crude	O	ADJ	I
venom	O	NOUN	I
,	O	PUNCT	O
were	O	AUX	O
investigated	O	VERB	B
on	O	ADP	O
lung	O	NOUN	B
and	O	CCONJ	O
cremaster	O	NOUN	B
vessels	O	NOUN	I
of	O	ADP	O
rats	O	NOUN	B
.	O	PUNCT	O


Possibility	O	NOUN	B
of	O	ADP	O
a	O	DET	O
TSH	B-GENE	NOUN	B
-	O	PUNCT	O
Screening	O	VERB	B
method	O	NOUN	O
for	O	ADP	O
detection	O	NOUN	B
of	O	ADP	O
hypothyroidism	O	NOUN	B
in	O	ADP	O
the	O	DET	O
newborn	O	ADJ	B


RESULTS	O	NOUN	B
:	O	PUNCT	O
Total	O	ADJ	B
IgE	B-GENE	NOUN	B
levels	O	NOUN	B
showed	O	VERB	O
a	O	DET	O
tendency	O	NOUN	O
to	O	PART	O
diminish	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
neuroleptic	O	ADJ	B
-	O	PUNCT	O
induced	O	VERB	B
increase	O	NOUN	B
in	O	ADP	O
central	O	ADJ	B
DA	O	NOUN	I
turnover	O	NOUN	I
(	O	PUNCT	O
an	O	DET	O
indicator	O	NOUN	B
for	O	ADP	O
the	O	DET	O
degree	O	NOUN	B
of	O	ADP	O
DA	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
blocking	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
positively	O	ADV	B
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
therapeutic	O	ADJ	B
effect	O	NOUN	I
of	O	ADP	O
neuroleptics	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
hypokinetic	O	ADJ	B
-	O	PUNCT	O
rigid	O	ADJ	B
symptoms	O	NOUN	B
.	O	PUNCT	O


Serum	O	NOUN	B
gastrin	B-GENE	NOUN	I
levels	O	NOUN	I
did	O	AUX	O
not	O	PART	O
change	O	VERB	O
in	O	ADP	O
either	O	DET	O
group	O	NOUN	B
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
background	O	NOUN	B
serum	O	NOUN	B
gastrin	B-GENE	NOUN	B
concentrations	O	NOUN	B
were	O	AUX	O
significantly	O	ADV	O
greater	O	ADJ	O
for	O	ADP	O
V	O	NOUN	O
&	O	CCONJ	O
P	O	NOUN	O
patients	O	NOUN	B
than	O	ADP	O
V	O	PROPN	B
&	O	CCONJ	I
A	O	NOUN	I
patients	O	NOUN	B
throughout	O	ADP	O
the	O	DET	O
study	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
calcitonin	B-GENE	NOUN	B
,	O	PUNCT	O
a	O	DET	O
large	O	ADJ	O
amount	O	NOUN	O
of	O	ADP	O
calcium	O	NOUN	B
given	O	VERB	O
orally	O	ADV	B
,	O	PUNCT	O
pentagastrin	O	NOUN	B
and	O	CCONJ	O
glucagon	B-GENE	NOUN	B
on	O	ADP	O
plasma	O	NOUN	B
47Ca	O	NOUN	O
radioactivity	O	NOUN	B
curves	O	NOUN	I
in	O	ADP	O
subjects	O	NOUN	B
pretreated	O	VERB	B
with	O	ADP	O
47Ca	O	NOUN	B
was	O	AUX	O
examined	O	VERB	B
.	O	PUNCT	O


Since	O	SCONJ	O
myoglobin	B-GENE	NOUN	B
is	O	AUX	O
co	O	ADV	B
-	O	PUNCT	O
extracted	O	VERB	B
with	O	ADP	O
the	O	DET	O
hemoglobin	B-GENE	NOUN	B
,	O	PUNCT	O
the	O	DET	O
2	O	NUM	O
heme	O	NOUN	B
pigments	O	NOUN	I
are	O	AUX	O
separated	O	VERB	O
in	O	ADP	O
one	O	NUM	O
portion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
extract	O	NOUN	B
by	O	ADP	O
precipitating	O	VERB	B
the	O	DET	O
hemoglobin	B-GENE	NOUN	B
in	O	ADP	O
an	O	DET	O
85	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
NH4	O	NOUN	B
)	O	PUNCT	O
2SO4	O	NOUN	B
solution	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
influence	O	NOUN	B
of	O	ADP	O
adrenergic	O	ADJ	B
nerves	O	NOUN	I
of	O	ADP	O
the	O	DET	O
response	O	NOUN	B
of	O	ADP	O
blood	O	NOUN	B
vessels	O	NOUN	I
in	O	ADP	O
the	O	DET	O
rabbit	O	NOUN	B
ear	O	NOUN	B
to	O	PART	O
2	B-GENE	NUM	O
-	I-GENE	PUNCT	O
-	I-GENE	PUNCT	O
phenylalanine	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
8	I-GENE	NUM	B
-	I-GENE	PUNCT	O
lysine	I-GENE	NOUN	B
vasopressin	I-GENE	NOUN	I
(	O	PUNCT	O
Octapressin	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Fibrin	B-GENE	NOUN	B
cloaking	O	NOUN	B
along	O	ADP	O
the	O	DET	O
catheter	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
in	O	ADP	O
20	O	NUM	O
patients	O	NOUN	B
studied	O	VERB	O
by	O	ADP	O
pull	O	NOUN	B
-	O	PUNCT	O
out	O	ADP	O
arteriography	O	NOUN	B
and	O	CCONJ	O
was	O	AUX	O
unassociated	O	ADJ	O
with	O	ADP	O
clinical	O	ADJ	B
symptoms	O	NOUN	I
.	O	PUNCT	O


Lymphocyte	O	NOUN	B
subpopulations	O	NOUN	I
,	O	PUNCT	O
serum	B-GENE	NOUN	B
IgE	I-GENE	NOUN	I
and	O	CCONJ	O
total	O	ADJ	O
eosinophil	O	NOUN	O
counts	O	NOUN	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
bronchial	O	ADJ	B
asthma	O	NOUN	I
.	O	PUNCT	O


IgG	B-GENE	NOUN	B
levels	O	NOUN	B
of	O	ADP	O
1	O	NUM	O
/	O	SYM	O
100	O	NUM	O
were	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
only	O	ADV	O
four	O	NUM	O
out	O	ADP	O
of	O	ADP	O
ten	O	NUM	O
samples	O	NOUN	B
obtained	O	VERB	O
150	O	NUM	O
days	O	NOUN	B
after	O	ADP	O
the	O	DET	O
clinical	O	ADJ	B
onset	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
other	O	ADJ	O
hypoglycaemic	O	ADJ	B
patient	O	NOUN	B
showed	O	VERB	O
an	O	DET	O
exaggerated	O	ADJ	B
insulin	B-GENE	NOUN	B
release	O	NOUN	O
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
tolbutamide	O	NOUN	B
.	O	PUNCT	O


Glucose	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
-	I-GENE	PUNCT	O
phosphate	I-GENE	NOUN	B
dehydrogenase	I-GENE	NOUN	I
(	O	PUNCT	O
G	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	B
-	I-GENE	PUNCT	O
PD	I-GENE	NOUN	B
)	O	PUNCT	O
deficiency	O	NOUN	B
in	O	ADP	O
the	O	DET	O
newborn	O	ADJ	B
.	O	PUNCT	O


The	O	DET	O
routine	O	ADJ	B
administration	O	NOUN	B
of	O	ADP	O
fat	O	ADJ	B
-	O	PUNCT	O
soluble	O	ADJ	B
vitamins	O	NOUN	B
appears	O	VERB	O
unnecessary	O	ADJ	O
but	O	CCONJ	O
it	O	PRON	O
is	O	AUX	O
prudent	O	ADJ	O
to	O	PART	O
measure	O	VERB	B
prothrombin	B-GENE	NOUN	B
time	O	NOUN	I
and	O	CCONJ	O
serum	O	NOUN	B
vitamins	O	NOUN	I
A	O	NOUN	I
and	O	CCONJ	O
E	O	NOUN	B
at	O	ADP	O
intervals	O	NOUN	B
.	O	PUNCT	O


Three	O	NUM	O
groups	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
who	O	PRON	O
had	O	AUX	O
undergone	O	VERB	O
subtotal	O	ADJ	B
thyroidectomy	O	NOUN	I
for	O	ADP	O
Graves	O	NOUN	B
'	O	PART	I
s	O	NOUN	I
disease	O	NOUN	I
,	O	PUNCT	O
toxic	O	ADJ	B
multinodular	O	ADJ	B
goitre	O	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
euthyroid	O	ADJ	B
multinodular	O	ADJ	B
goitre	O	NOUN	I
12	O	NUM	O
to	O	PART	O
15	O	NUM	O
years	O	NOUN	B
before	O	ADP	O
and	O	CCONJ	O
in	O	ADP	O
whom	O	PRON	O
a	O	DET	O
normal	O	ADJ	O
serum	O	NOUN	O
thyroxine	O	NOUN	O
(	O	PUNCT	O
T	O	NOUN	B
-	O	PUNCT	O
4	O	NUM	O
)	O	PUNCT	O
level	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
were	O	AUX	O
each	O	DET	O
divided	O	VERB	O
into	O	ADP	O
two	O	NUM	O
subgroups	O	NOUN	B
on	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
a	O	DET	O
normal	O	ADJ	B
or	O	CCONJ	O
a	O	DET	O
raised	O	VERB	O
serum	O	NOUN	B
thyrotrophin	B-GENE	NOUN	O
concentration	O	NOUN	B
.	O	PUNCT	O


Besides	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
in	O	ADP	O
3	O	NUM	O
patients	O	NOUN	B
increased	O	VERB	B
serum	B-GENE	NOUN	B
immunoglobulins	I-GENE	NOUN	O
,	O	PUNCT	O
chiefly	O	ADJ	O
IgG	B-GENE	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
first	O	ADJ	O
Russe	O	PROPN	B
,	O	PUNCT	O
Busey	O	PROPN	B
and	O	CCONJ	O
Barbeau	O	PROPN	B
demonstrated	O	VERB	O
in	O	ADP	O
a	O	DET	O
large	O	ADJ	O
French	O	PROPN	B
-	O	PUNCT	O
Canadian	O	ADJ	B
family	O	NOUN	B
.	O	PUNCT	O


3	O	NUM	O
activities	O	NOUN	B
of	O	ADP	O
the	O	DET	O
factor	B-GENE	NOUN	B
II	I-GENE	NUM	I
molecule	O	NOUN	I
in	O	ADP	O
the	O	DET	O
newborn	O	ADJ	B
infant	O	NOUN	I
at	O	ADP	O
term	O	NOUN	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
insulin	B-GENE	NOUN	B
response	O	NOUN	I
had	O	AUX	O
returned	O	VERB	O
to	O	ADP	O
the	O	DET	O
non	O	ADJ	B
-	O	PUNCT	O
pregnant	O	ADJ	B
value	O	NOUN	I
by	O	ADP	O
the	O	DET	O
second	O	ADJ	O
day	O	NOUN	B
of	O	ADP	O
the	O	DET	O
puerperium	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
describe	O	VERB	O
and	O	CCONJ	O
map	O	VERB	B
two	O	NUM	O
more	O	ADV	O
new	O	ADJ	O
genes	O	NOUN	B
identified	O	VERB	B
as	O	ADP	O
allele	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
suppressors	O	NOUN	B
that	O	PRON	O
compensate	O	VERB	B
for	O	ADP	O
carboxy	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
truncation	O	NOUN	B
of	O	ADP	O
PET122	B-GENE	NOUN	B
.	O	PUNCT	O


Rabbit	B-GENE	VERB	B
skeletal	I-GENE	ADJ	B
muscle	I-GENE	NOUN	I
glycogenin	I-GENE	NOUN	B
.	O	PUNCT	O


Characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
gene	I-GENE	NOUN	I
encoding	I-GENE	VERB	O
cytokeratin	I-GENE	NOUN	B
17	I-GENE	NUM	I
and	O	CCONJ	O
its	O	PRON	O
expression	O	NOUN	B
pattern	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
statistically	O	ADV	B
significant	O	ADJ	I
improvement	O	NOUN	B
due	O	ADJ	O
to	O	ADP	O
the	O	DET	O
administration	O	NOUN	B
of	O	ADP	O
Bromergon	O	PROPN	B
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
symptoms	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
overreactiveness	O	NOUN	B
to	O	PART	O
normal	O	ADJ	O
prolactin	B-GENE	NOUN	B
levels	O	NOUN	I
,	O	PUNCT	O
i	O	X	O
.	O	PUNCT	O
e	O	X	O
.	O	PUNCT	O
abdominal	O	ADJ	B
tension	O	NOUN	I
,	O	PUNCT	O
edema	O	NOUN	B
,	O	PUNCT	O
weight	O	NOUN	B
gain	O	NOUN	I
and	O	CCONJ	O
breast	O	NOUN	B
tenderness	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
7	O	NUM	O
of	O	ADP	O
9	O	NUM	O
cases	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
enhancer	O	NOUN	B
is	O	AUX	O
fused	O	VERB	B
to	O	PART	O
the	O	DET	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
myc	I-GENE	NOUN	B
bearing	I-GENE	VERB	O
sequences	I-GENE	NOUN	O
of	O	ADP	O
chromosome	O	NOUN	O
8	O	NUM	O
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
UCRBP	B-GENE	NOUN	B
binds	O	VERB	B
to	O	PART	O
various	O	ADJ	O
target	O	NOUN	B
motifs	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
distinct	O	ADJ	O
from	O	ADP	O
the	O	DET	O
UCR	O	NOUN	B
motif	O	NOUN	B
:	O	PUNCT	O
the	O	DET	O
adeno	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
associated	I-GENE	VERB	B
virus	I-GENE	NOUN	B
P5	I-GENE	NOUN	I
promoter	I-GENE	NOUN	B
and	O	CCONJ	O
elements	O	NOUN	B
in	O	ADP	O
the	O	DET	O
immunoglobulin	B-GENE	NOUN	B
light	I-GENE	ADJ	I
-	I-GENE	PUNCT	O
and	I-GENE	CCONJ	O
heavy	I-GENE	ADJ	B
-	I-GENE	PUNCT	O
chain	I-GENE	NOUN	B
genes	O	NOUN	I
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
elements	O	NOUN	B
in	O	ADP	O
ribosomal	B-GENE	ADJ	B
protein	I-GENE	NOUN	I
genes	I-GENE	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
both	O	CCONJ	O
N	O	NOUN	B
-	O	PUNCT	O
and	O	CCONJ	O
C	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
mutations	O	NOUN	B
are	O	AUX	O
required	O	VERB	O
to	O	PART	O
inhibit	O	VERB	B
transrepression	O	NOUN	B
by	O	ADP	O
FBR	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
and	O	CCONJ	O
that	O	SCONJ	O
multiple	O	ADJ	O
structural	O	ADJ	B
mutations	O	NOUN	I
accompanied	O	VERB	O
by	O	ADP	O
posttranslational	O	ADJ	B
protein	O	NOUN	I
modification	O	NOUN	O
alter	O	VERB	O
gene	O	NOUN	B
regulation	O	NOUN	I
by	O	ADP	O
FBR	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
predicted	O	VERB	O
receptor	O	NOUN	B
structure	O	NOUN	I
includes	O	VERB	O
a	O	DET	O
cysteine	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
extracellular	O	ADJ	O
domain	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
single	O	ADJ	O
hydrophobic	O	ADJ	B
transmembrane	O	ADJ	O
domain	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
predicted	O	VERB	O
cytoplasmic	B-GENE	ADJ	B
serine	I-GENE	NOUN	B
/	I-GENE	PUNCT	O
threonine	I-GENE	NOUN	B
kinase	I-GENE	NOUN	I
domain	I-GENE	NOUN	I
.	O	PUNCT	O


Drosophila	B-GENE	X	B
UbcD1	I-GENE	NOUN	B
encodes	O	VERB	O
a	O	DET	O
highly	O	ADV	O
conserved	O	VERB	O
ubiquitin	B-GENE	NOUN	B
-	O	PUNCT	O
conjugating	O	VERB	B
enzyme	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
selective	O	ADJ	O
protein	O	NOUN	B
degradation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
goal	O	NOUN	B
of	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
was	O	AUX	O
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
feasibility	O	NOUN	B
of	O	ADP	O
retrovirus	O	NOUN	B
mediated	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
rp47phox	B-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
HL60	O	NOUN	B
and	O	CCONJ	O
U937	O	NOUN	B
human	O	ADJ	O
hematopoietic	O	ADJ	B
cell	O	NOUN	I
lines	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
an	O	DET	O
Epstein	O	PROPN	B
-	O	PUNCT	O
Barr	O	PROPN	B
virus	O	NOUN	I
transformed	O	VERB	B
B	O	NOUN	I
-	O	PUNCT	O
lymphocyte	O	NOUN	B
cell	O	NOUN	I
line	O	NOUN	I
(	O	PUNCT	O
EBV	O	NOUN	B
-	O	PUNCT	O
BCL	O	NOUN	B
)	O	PUNCT	O
derived	O	VERB	O
from	O	ADP	O
a	O	DET	O
p47phox	B-GENE	NOUN	B
-	O	PUNCT	O
deficient	O	ADJ	B
CGD	O	NOUN	B
patient	O	NOUN	B
.	O	PUNCT	O


Both	O	CCONJ	O
in	O	X	B
vitro	O	X	I
-	O	PUNCT	O
synthesized	O	VERB	B
S2	B-GENE	NOUN	O
protein	I-GENE	NOUN	O
and	O	CCONJ	O
synthetic	O	ADJ	B
peptides	O	NOUN	I
corresponding	O	VERB	O
to	O	PART	O
S2	B-GENE	NOUN	B
are	O	AUX	O
shown	O	VERB	O
to	O	PART	O
react	O	VERB	O
positively	O	ADV	B
with	O	ADP	O
sera	O	NOUN	B
obtained	O	VERB	O
from	O	ADP	O
EIAV	O	NOUN	B
-	O	PUNCT	O
infected	O	VERB	B
horses	O	NOUN	B
,	O	PUNCT	O
providing	O	VERB	O
the	O	DET	O
first	O	ADJ	O
direct	O	ADJ	O
evidence	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
this	O	DET	O
protein	O	NOUN	B
in	O	ADP	O
infected	O	ADJ	B
animals	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
DNA	O	NOUN	B
sequence	O	NOUN	I
of	O	ADP	O
the	O	DET	O
sulfate	B-GENE	NOUN	B
activation	I-GENE	NOUN	I
locus	I-GENE	NOUN	I
from	O	ADP	O
Escherichia	O	X	B
coli	O	X	I
K	O	PROPN	I
-	O	PUNCT	O
12	O	NUM	O
has	O	AUX	O
been	O	AUX	O
determined	O	VERB	O
.	O	PUNCT	O


Plasma	O	NOUN	B
membranes	O	NOUN	I
of	O	ADP	O
cultured	O	VERB	B
cells	O	NOUN	I
contain	O	VERB	O
high	O	ADJ	O
affinity	O	NOUN	B
receptors	O	NOUN	I
for	O	ADP	O
high	B-GENE	ADJ	B
density	I-GENE	NOUN	I
lipoprotein	I-GENE	NOUN	I
(	O	PUNCT	I
HDL	B-GENE	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
appear	O	VERB	O
to	O	PART	O
mediate	O	VERB	O
removal	O	NOUN	B
of	O	ADP	O
excess	O	ADJ	B
intracellular	O	ADJ	B
cholesterol	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
recombinant	O	NOUN	B
with	O	ADP	O
a	O	DET	O
5	O	NUM	O
'	O	PART	O
end	O	NOUN	O
from	O	ADP	O
src	B-GENE	NOUN	B
and	O	CCONJ	O
a	O	DET	O
3	O	NUM	O
'	O	PART	O
end	O	NOUN	O
from	O	ADP	O
ros	B-GENE	NOUN	B
,	O	PUNCT	O
called	O	VERB	O
SRC	B-GENE	NOUN	B
x	O	NOUN	O
ROS	B-GENE	NOUN	B
,	O	PUNCT	O
transformed	O	VERB	B
chicken	O	NOUN	I
embryo	O	NOUN	B
fibroblasts	O	NOUN	B
(	O	PUNCT	O
CEF	O	NOUN	B
)	O	PUNCT	O
to	O	PART	O
a	O	DET	O
spindle	O	NOUN	B
shape	O	NOUN	B
morphology	O	NOUN	B
,	O	PUNCT	O
mimicking	O	VERB	B
that	O	DET	O
of	O	ADP	O
UR2	B-GENE	NOUN	B
.	O	PUNCT	O


ROS	B-GENE	NOUN	B
x	O	NOUN	O
SRC	B-GENE	NOUN	B
(	O	PUNCT	O
R	B-GENE	NOUN	B
)	O	PUNCT	O
contains	O	VERB	O
a	O	DET	O
16	O	NUM	O
-	O	PUNCT	O
amino	O	NOUN	B
-	O	PUNCT	O
acid	O	NOUN	B
deletion	O	NOUN	B
that	O	PRON	O
includes	O	VERB	O
the	O	DET	O
3	O	NUM	O
'	O	PUNCT	O
half	O	NOUN	O
of	O	ADP	O
the	O	DET	O
transmembrane	O	ADJ	B
domain	O	NOUN	I
of	O	ADP	O
ros	B-GENE	NOUN	B
.	O	PUNCT	O


Transient	O	ADJ	B
transfection	O	NOUN	O
assays	O	NOUN	O
showed	O	VERB	O
that	O	SCONJ	O
site	O	NOUN	B
A	O	NOUN	O
is	O	AUX	O
necessary	O	ADJ	O
and	O	CCONJ	O
sufficient	O	ADJ	B
for	O	ADP	O
RXR	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
-	O	PUNCT	O
mediated	O	VERB	B
transactivation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
apoAI	B-GENE	NOUN	B
gene	I-GENE	NOUN	O
basal	I-GENE	ADJ	B
promoter	I-GENE	NOUN	I
in	O	ADP	O
human	O	ADJ	B
hepatoma	O	NOUN	B
HepG2	O	NOUN	B
cells	O	NOUN	I
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
RA	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
this	O	DET	O
transactivation	O	NOUN	B
is	O	AUX	O
abolished	O	VERB	O
by	O	ADP	O
increasing	O	VERB	B
amounts	O	NOUN	O
of	O	ADP	O
cotransfected	O	VERB	B
ARP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
.	O	PUNCT	O


Antibodies	O	NOUN	B
against	O	ADP	O
this	O	DET	O
purified	O	VERB	O
protein	O	NOUN	O
localize	O	VERB	O
RIM1	B-GENE	NOUN	B
to	O	PART	O
mitochondria	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
position	O	NOUN	B
-	O	PUNCT	O
independent	O	ADJ	B
activation	O	NOUN	B
domain	O	NOUN	I
which	O	DET	O
contained	O	VERB	O
conserved	O	VERB	B
regions	O	NOUN	I
II	O	NUM	I
and	O	CCONJ	O
III	O	NUM	B
was	O	AUX	O
identified	O	VERB	B
at	O	ADP	O
the	O	DET	O
carboxyl	O	NOUN	B
terminus	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HNF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	B
beta	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
(	O	PUNCT	O
amino	O	NOUN	B
acids	O	NOUN	I
361	O	NUM	O
to	O	PART	O
458	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


HNF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	O
beta	I-GENE	NOUN	B
amino	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
terminal	I-GENE	ADJ	B
sequences	I-GENE	NOUN	B
defined	O	VERB	O
by	O	ADP	O
conserved	O	VERB	B
region	O	NOUN	I
IV	O	NUM	I
also	O	ADV	O
contributed	O	VERB	O
to	O	PART	O
transactivation	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
region	O	NOUN	B
IV	O	NUM	I
activity	O	NOUN	B
required	O	VERB	O
the	O	DET	O
participation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
region	O	NOUN	B
II	O	NUM	I
-	O	PUNCT	O
III	O	NUM	B
domain	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
hit1	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
mutation	O	NOUN	B
caused	O	VERB	O
a	O	DET	O
defect	O	NOUN	B
in	O	ADP	O
synthesis	O	NOUN	B
of	O	ADP	O
a	O	DET	O
74	B-GENE	NUM	O
-	I-GENE	PUNCT	O
kD	I-GENE	NOUN	B
heat	I-GENE	NOUN	B
shock	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
319	O	NUM	O
base	O	NOUN	B
pair	O	NOUN	I
region	O	NOUN	I
immediately	O	ADV	O
upstream	O	ADV	B
of	O	ADP	O
the	O	DET	O
CAP	O	NOUN	B
site	O	NOUN	B
is	O	AUX	O
characterized	O	VERB	B
by	O	ADP	O
the	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
a	O	DET	O
proximal	O	ADJ	B
TATA	O	NOUN	O
box	O	NOUN	O
and	O	CCONJ	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
sequences	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
GC	O	NOUN	B
boxes	O	NOUN	I
,	O	PUNCT	O
CACCC	O	NOUN	B
boxes	O	NOUN	I
,	O	PUNCT	O
CCAAT	O	NOUN	B
boxes	O	NOUN	I
,	O	PUNCT	O
activator	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
2	I-GENE	NUM	I
(	O	PUNCT	O
Ap	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
)	O	PUNCT	O
sites	O	NOUN	B
,	O	PUNCT	O
partial	O	ADJ	B
glucocorticoid	O	NOUN	B
response	O	NOUN	I
elements	O	NOUN	I
(	O	PUNCT	O
GREs	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
partial	O	ADJ	B
cyclic	O	ADJ	B
AMP	O	NOUN	O
response	O	NOUN	O
elements	O	NOUN	O
(	O	PUNCT	O
CREs	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
MAP	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
activator	I-GENE	NOUN	I
/	O	SYM	O
MAP	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
system	O	NOUN	I
may	O	AUX	O
be	O	AUX	O
the	O	DET	O
downstream	O	ADJ	B
components	O	NOUN	O
of	O	ADP	O
ras	B-GENE	NOUN	B
signal	O	NOUN	I
transduction	O	NOUN	I
pathways	O	NOUN	I
.	O	PUNCT	O


Labile	O	ADJ	B
LTR	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
proteins	I-GENE	NOUN	I
appear	O	VERB	O
to	O	PART	O
be	O	AUX	O
essential	O	ADJ	B
for	O	ADP	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
myc	I-GENE	NOUN	B
hyperexpression	O	NOUN	B
,	O	PUNCT	O
since	O	SCONJ	O
both	O	CCONJ	O
LTR	O	NOUN	B
-	O	PUNCT	O
enhanced	O	VERB	B
transcription	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
activities	O	NOUN	B
of	O	ADP	O
LTR	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
proteins	I-GENE	NOUN	I
are	O	AUX	O
specifically	O	ADV	O
decreased	O	VERB	B
after	O	ADP	O
inhibition	O	NOUN	B
of	O	ADP	O
protein	O	NOUN	B
synthesis	O	NOUN	I
(	O	PUNCT	O
A	O	NOUN	O
.	O	PUNCT	O


Truncation	O	NOUN	B
variants	O	NOUN	B
of	O	ADP	O
peptides	O	NOUN	B
isolated	O	VERB	B
from	O	ADP	O
MHC	B-GENE	NOUN	B
class	I-GENE	NOUN	I
II	I-GENE	NUM	I
molecules	I-GENE	NOUN	I
suggest	O	VERB	O
sequence	O	NOUN	B
motifs	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
the	O	DET	O
E	O	PROPN	B
-	O	PUNCT	O
box	O	NOUN	B
consensus	O	NOUN	O
is	O	AUX	O
minimally	O	ADV	O
defined	O	VERB	O
as	O	ADP	O
CANNTG	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
adjacent	O	ADJ	B
nucleotides	O	NOUN	B
of	O	ADP	O
functional	O	ADJ	B
E	O	NOUN	I
-	O	PUNCT	O
boxes	O	NOUN	B
are	O	AUX	O
variable	O	ADJ	B
for	O	ADP	O
genes	O	NOUN	B
regulated	O	VERB	B
by	O	ADP	O
the	O	DET	O
bHLH	B-GENE	ADJ	B
proteins	I-GENE	NOUN	I
.	O	PUNCT	O


T	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
cell	I-GENE	NOUN	B
receptor	I-GENE	NOUN	I
beta	I-GENE	NOUN	I
(	O	PUNCT	I
TCR	B-GENE	NOUN	O
beta	I-GENE	NOUN	O
)	O	PUNCT	O
gene	O	NOUN	B
rearrangements	O	NOUN	I
occur	O	VERB	O
in	O	ADP	O
a	O	DET	O
third	O	NOUN	O
of	O	ADP	O
early	O	ADJ	B
B	O	NOUN	B
-	O	PUNCT	O
cell	O	NOUN	B
acute	O	ADJ	B
lymphoblastic	O	ADJ	I
leukemias	O	NOUN	I
(	O	PUNCT	O
ALLs	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
cloned	O	VERB	B
and	O	CCONJ	O
sequenced	O	VERB	B
COX12	B-GENE	NOUN	B
,	O	PUNCT	O
the	O	DET	O
nuclear	O	ADJ	B
gene	O	NOUN	I
for	O	ADP	O
subunit	B-GENE	NOUN	B
VIb	I-GENE	NOUN	I
of	O	ADP	O
Saccharomyces	B-GENE	X	B
cerevisiae	I-GENE	X	I
cytochrome	I-GENE	NOUN	B
c	I-GENE	NOUN	I
oxidase	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
basal	O	ADJ	B
promoter	O	NOUN	O
elements	O	NOUN	O
of	O	ADP	O
murine	B-GENE	ADJ	B
cytochrome	I-GENE	NOUN	B
c	I-GENE	NOUN	I
oxidase	I-GENE	NOUN	I
subunit	I-GENE	NOUN	I
IV	I-GENE	NUM	I
gene	I-GENE	NOUN	O
consist	O	VERB	O
of	O	ADP	O
tandemly	O	ADJ	B
duplicated	O	ADJ	O
ets	B-GENE	NOUN	B
motifs	O	NOUN	I
that	O	PRON	O
bind	O	VERB	B
to	O	PART	O
GABP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
related	I-GENE	VERB	B
transcription	I-GENE	NOUN	B
factors	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
minimal	O	ADJ	B
promoter	O	NOUN	B
of	O	ADP	O
the	O	DET	O
RII	B-GENE	NOUN	B
beta	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
was	O	AUX	O
composed	O	VERB	O
of	O	ADP	O
two	O	NUM	O
adjacent	O	ADJ	B
functional	O	ADJ	B
elements	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
major	O	ADJ	O
mechanism	O	NOUN	B
whereby	O	SCONJ	O
steroid	B-GENE	NOUN	B
hydroxylase	I-GENE	NOUN	I
gene	I-GENE	NOUN	B
transcription	O	NOUN	I
is	O	AUX	O
regulated	O	VERB	O
in	O	ADP	O
the	O	DET	O
adrenal	O	ADJ	B
cortex	O	NOUN	I
requires	O	VERB	O
the	O	DET	O
pituitary	O	ADJ	B
peptide	O	NOUN	I
hormone	O	NOUN	I
,	O	PUNCT	O
ACTH	B-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
acts	O	VERB	O
via	O	ADP	O
cAMP	O	NOUN	B
.	O	PUNCT	O


Km	O	NOUN	B
and	O	CCONJ	O
Vmax	O	NOUN	B
for	O	ADP	O
two	O	NUM	O
substrates	O	NOUN	B
,	O	PUNCT	O
src	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
related	I-GENE	VERB	B
peptide	I-GENE	NOUN	B
and	O	CCONJ	O
poly	O	NOUN	B
(	O	PUNCT	I
Glu	O	NOUN	B
,	O	PUNCT	O
Tyr	O	NOUN	B
)	O	PUNCT	O
(	O	PUNCT	O
4	O	NUM	O
:	O	PUNCT	O
1	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
were	O	AUX	O
2	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
mM	O	NOUN	O
and	O	CCONJ	O
2	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
mumol	O	NOUN	O
min	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
mg	O	NOUN	O
-	O	PUNCT	O
1	O	NUM	O
and	O	CCONJ	O
0	O	NUM	O
.	O	PUNCT	O
26	O	NUM	O
mM	O	NOUN	O
and	O	CCONJ	O
1	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
mumol	O	NOUN	O
min	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
mg	O	NOUN	O
-	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


The	O	DET	O
ORF1	O	NOUN	B
protein	O	NOUN	I
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
highly	O	ADV	O
homologous	O	ADJ	B
to	O	PART	O
the	O	DET	O
putative	O	ADJ	B
potexvirus	B-GENE	NOUN	I
RNA	I-GENE	NOUN	I
replicases	I-GENE	NOUN	I
;	O	PUNCT	O
ORF2	O	NOUN	B
,	O	PUNCT	O
-	O	PUNCT	O
3	O	NUM	O
,	O	PUNCT	O
-	O	PUNCT	O
5	O	NUM	O
and	O	CCONJ	O
-	O	PUNCT	O
6	O	NUM	O
proteins	O	NOUN	B
also	O	ADV	O
have	O	AUX	O
analogues	O	NOUN	B
among	O	ADP	O
the	O	DET	O
potex	O	NOUN	B
-	O	PUNCT	O
and	O	CCONJ	O
/	O	SYM	O
or	O	CCONJ	O
carlavirus	O	NOUN	B
-	O	PUNCT	O
encoded	O	VERB	B
proteins	O	NOUN	B
.	O	PUNCT	O


Characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
regulon	O	NOUN	B
controlled	O	VERB	B
by	O	ADP	O
the	O	DET	O
leucine	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
responsive	I-GENE	ADJ	B
regulatory	I-GENE	ADJ	B
protein	I-GENE	NOUN	I
in	O	ADP	O
Escherichia	O	X	B
coli	O	X	I
.	O	PUNCT	O


This	O	DET	O
mutation	O	NOUN	B
also	O	ADV	O
results	O	VERB	B
in	O	ADP	O
markedly	O	ADV	O
decreased	O	VERB	B
levels	O	NOUN	B
of	O	ADP	O
CAD	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
in	O	ADP	O
the	O	DET	O
mutant	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
pol	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
-	O	PUNCT	O
primase	B-GENE	NOUN	B
complex	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
act	O	VERB	O
processively	O	ADV	B
for	O	ADP	O
only	O	ADV	O
a	O	DET	O
short	O	ADJ	B
distance	O	NOUN	I
.	O	PUNCT	O


